Revathy, Nadhan and Priya, Srinivas and Pillai, M. R (2020) RTKs in pathobiology of head and neck cancers. Advances in Cancer Research, 147. pp. 319-373. ISSN 0065-230X

Full text not available from this repository.

Abstract

Non-communicable diseases contribute to 71% of the deaths worldwide, of which cancers rank second after cardiovascular diseases. Among all the cancers, head and neck cancers (HNC) are consequential in augmenting the global cancer incidence as well as mortality. Receptor tyrosine kinases (RTKs) are emphatic for the matter that they serve as biomarkers aiding the analysis of tumor progression and metastasis as well as diagnosis, prognosis and therapeutic progression in the patients. The extensive researches on HNC have made significant furtherance in numerous targeted therapies, but for the escalating therapeutic resistance. This review explicates RTKs in HNC, their signaling pathways involved in tumorigenesis, metastasis and stemness induction, the association of non-coding RNAs with RTKs, an overview of RTK based therapy and associated resistance in HNC, as well as a sneak peek into the HPV positive HNC and its therapy. The review extrapolates the cardinal role of RTKs and RTK based therapy as superior to other existing therapeutic interventions for HNC.

Item Type:	Article
Uncontrolled Keywords:	Receptor tyrosine kinase Head and neck cancer EGFR miRNA HPV Oral cancer
Subjects:	Cancer Research
Depositing User:	Central Library RGCB
Date Deposited:	17 Mar 2021 07:46
Last Modified:	17 Mar 2021 07:46
URI:	http://rgcb.sciencecentral.in/id/eprint/1022

Actions (login required)

View Item